TrialThe Lancet. Respiratory medicine2023

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.

Samuel M Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.